Latest Insider Transactions at Encompass Health Corp (EHC)
This section provides a real-time view of insider transactions for Encompass Health Corp (EHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Encompass Health Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Encompass Health Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 06
2021
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,757
+5.34%
|
-
|
|
May 06
2021
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,757
+26.53%
|
-
|
|
May 06
2021
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,757
+2.15%
|
-
|
|
May 06
2021
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,757
+15.0%
|
-
|
|
May 06
2021
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,757
+1.76%
|
-
|
|
May 06
2021
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,757
+26.53%
|
-
|
|
May 05
2021
|
April Kaye Bullock Anthony CEO & President, Home Health |
SELL
Payment of exercise price or tax liability
|
Direct |
6,538
-1.65%
|
$549,192
$84.68 P/Share
|
|
May 05
2021
|
April Kaye Bullock Anthony CEO & President, Home Health |
BUY
Exercise of conversion of derivative security
|
Direct |
7,583
+1.88%
|
$530,810
$70.16 P/Share
|
|
May 03
2021
|
April Kaye Bullock Anthony CEO & President, Home Health |
SELL
Payment of exercise price or tax liability
|
Direct |
3,637
-1.85%
|
$305,508
$84.44 P/Share
|
|
Apr 16
2021
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+0.14%
|
$14,028
$84.27 P/Share
|
|
Apr 16
2021
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.01%
|
$588
$84.29 P/Share
|
|
Apr 16
2021
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
50
+0.05%
|
$4,200
$84.35 P/Share
|
|
Apr 15
2021
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.35%
|
-
|
|
Apr 15
2021
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
236
+0.2%
|
-
|
|
Apr 15
2021
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
247
+0.33%
|
-
|
|
Apr 15
2021
|
Yvonne M Curl Director |
BUY
Grant, award, or other acquisition
|
Direct |
247
+0.33%
|
-
|
|
Apr 15
2021
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
247
+0.31%
|
-
|
|
Apr 15
2021
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+0.33%
|
-
|
|
Apr 15
2021
|
Leo I Higdon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
247
+0.32%
|
-
|
|
Apr 15
2021
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+0.33%
|
-
|
|
Apr 15
2021
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.35%
|
-
|
|
Apr 15
2021
|
John E Jr D D S Maupin Director |
BUY
Grant, award, or other acquisition
|
Direct |
247
+0.31%
|
-
|
|
Apr 15
2021
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.34%
|
-
|
|
Apr 15
2021
|
L Edward Shaw Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
247
+0.26%
|
-
|
|
Apr 15
2021
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.35%
|
-
|
|
Mar 08
2021
|
Andrew L Price Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,589
-11.89%
|
$695,709
$81.4 P/Share
|
|
Feb 24
2021
|
April Kaye Bullock Anthony CEO & President, Home Health |
BUY
Grant, award, or other acquisition
|
Direct |
5,673
+1.43%
|
-
|
|
Feb 24
2021
|
Elissa Joy Charbonneau Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,507
+10.02%
|
-
|
|
Feb 24
2021
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,992
+8.44%
|
-
|
|
Feb 24
2021
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,690
+8.21%
|
-
|
|
Feb 24
2021
|
Edmund Fay Sr. Vice Pres. and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,787
+2.08%
|
-
|
|
Feb 24
2021
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
BUY
Grant, award, or other acquisition
|
Direct |
11,479
+10.92%
|
-
|
|
Feb 24
2021
|
Andrew L Price Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,894
+2.66%
|
-
|
|
Feb 24
2021
|
Mark J Tarr President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,137
+5.21%
|
-
|
|
Feb 23
2021
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
356
-2.07%
|
$28,480
$80.23 P/Share
|
|
Feb 23
2021
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
790
-1.21%
|
$63,200
$80.23 P/Share
|
|
Feb 23
2021
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
401
-1.09%
|
$32,080
$80.23 P/Share
|
|
Feb 23
2021
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-0.36%
|
$24,960
$80.23 P/Share
|
|
Feb 23
2021
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-1.23%
|
$37,280
$80.23 P/Share
|
|
Feb 23
2021
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
314
-0.46%
|
$25,120
$80.23 P/Share
|
|
Feb 23
2021
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,975
-0.55%
|
$158,000
$80.23 P/Share
|
|
Feb 21
2021
|
April Kaye Bullock Anthony CEO & President, Home Health |
SELL
Payment of exercise price or tax liability
|
Direct |
142
-0.07%
|
$11,360
$80.51 P/Share
|
|
Feb 21
2021
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
328
-1.87%
|
$26,240
$80.51 P/Share
|
|
Feb 21
2021
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-0.99%
|
$29,280
$80.51 P/Share
|
|
Feb 21
2021
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
275
-0.32%
|
$22,000
$80.51 P/Share
|
|
Feb 21
2021
|
Barbara Ann Jacobsmeyer President & CEO, HHH |
SELL
Payment of exercise price or tax liability
|
Direct |
505
-1.32%
|
$40,400
$80.51 P/Share
|
|
Feb 21
2021
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
277
-0.4%
|
$22,160
$80.51 P/Share
|
|
Feb 21
2021
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,039
-0.57%
|
$163,120
$80.51 P/Share
|
|
Feb 21
2021
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
621
-0.95%
|
$49,680
$80.51 P/Share
|
|
Feb 20
2021
|
April Kaye Bullock Anthony CEO & President, Home Health |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-0.11%
|
$16,400
$80.51 P/Share
|